|
|
|
IMF reports from the 2004 annual meeting of the American Society of Hematology in San Diego, California. A special, CME-accredited program, Controversies in Myeloma Management, brought together leading experts to discuss clinical practice issues in the context of patient case studies.
|
|
CONTROVERSIES IN MYELOMA MANAGEMENT
This CME-certified symposium entitled “Controversies in Myeloma Management: Diagnosis, Initial Treatment, and the Relapsing Patient” was jointly sponsored by the IMF and the Institute for Continuing Healthcare Education, an ACCME-accredited provider of continuing medical education.
|
back
print
back to top